NCT05572567View on ClinicalTrials.gov

Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

1,972

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

October 10, 2022

Study Completion Date

October 10, 2022

Conditions
Arthritis, Rheumatoid
Trial Locations (1)

Unknown

Pfizer, Tokyo

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY